OPT 0.00% 64.0¢ opthea limited

News: OPT Opthea Completes Enrollment In First Trial With Sozinibercept

  1. 187,940 Posts.
    lightbulb Created with Sketch. 2760

    Feb 14 (Reuters) - Opthea Ltd (OPT) :

    • OPTHEA LTD- COMPLETES ENROLLMENT IN FIRST TRIAL WITH SOZINIBERCEPT
    • OPTHEA LTD- ENROLLMENT OF SECOND PIVOTAL TRIAL TO COMPLETE IN CALENDAR Q2 2024
    • OPTHEA LTD- POSITIVE RESULTS FROM PHASE 2B STUDY OF SOZINIBERCEPT MET PRE-SPECIFIED PRIMARY EFFICACY ENDPOINT
    • OPTHEA LTD- SECONDARY OUTCOMES WERE POSITIVE FOR COMBINATION THERAPY WITH SOZINIBERCEPT
    • OPTHEA LTD- TOP-LINE RESULTS FROM TWO PHASE 3 PIVOTAL TRIALS, COAST AND SHORE, EXPECTED BY MID-2025
 
watchlist Created with Sketch. Add OPT (ASX) to my watchlist
(20min delay)
Last
64.0¢
Change
0.000(0.00%)
Mkt cap ! $424.1M
Open High Low Value Volume
63.5¢ 64.0¢ 62.5¢ $1.233M 1.957M

Buyers (Bids)

No. Vol. Price($)
1 10000 62.5¢
 

Sellers (Offers)

Price($) Vol. No.
64.0¢ 13999 2
View Market Depth
Last trade - 16.10pm 22/05/2024 (20 minute delay) ?
Last
62.8¢
  Change
0.000 ( 0.38 %)
Open High Low Volume
63.5¢ 63.8¢ 62.5¢ 59501
Last updated 15.59pm 22/05/2024 ?
OPT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.